Safety and Clinical Performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Stents in Routine Practice

The goal of this observational study is to collect safety and performance information in the setting of a large-scale clinical registry.

Patients meeting the selection criteria will be included, in chronological order of their implantation. This registry does not require any additional procedures, follow-up interventions, or ionizing radiation for patients.

The inclusion period is planned to last 2 years, starting in Q1 2023. The study will be complete when data on all patient's follow-up for one year have been collected.

- Prospective, observational, noninterventional, multicenter, international clinical registry
- Allocation: consecutively treated patients, non-randomized
- Masking: None (open label)
- Observational model: Longitudinal
- Inclusion period: 2 years
- Follow-up period: at 1 year
- Study duration: 3 years

Patients meeting the selection criteria will be included, in chronological order of their implantation. This registry does not require any additional procedures, follow-up interventions, or ionizing radiation for patients.

The inclusion period is planned to last 2 years, starting in Q1 2023. The study will be complete when data on all patient's follow-up for one year have been collected.

List of visits:
- V0: During hospitalization: consultation baseline, data of the intervention and data at discharge
- V1: consultation at 30 days Follow-Up
- V2: consultation at 12 months Follow-Up